molsidomine has been researched along with natriuretic peptide, c-type in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fulep, E; Garfield, RE; Saade, GR; Vedernikov, Y | 1 |
| Cho, KW; Cui, X; Jin, JY; Kim, SH; Kim, SM; Kim, SZ; Lee, HS; Wen, JF | 1 |
| Bonatti, J; Fersterer, J; Hammerer-Lercher, A; Hoefer, D; Holzmann, S; Mair, J; Puschendorf, B; Ruttmann, E | 1 |
3 other study(ies) available for molsidomine and natriuretic peptide, c-type
| Article | Year |
|---|---|
Contractility of late pregnant rat myometrium is refractory to activation of soluble but not particulate guanylate cyclase.
Topics: Animals; Atrial Natriuretic Factor; Dose-Response Relationship, Drug; Enzyme Activation; Female; Guanylate Cyclase; Hydrazines; Molsidomine; Natriuretic Peptide, Brain; Natriuretic Peptide, C-Type; Nitric Oxide; Nitric Oxide Donors; Nitrogen Oxides; Pregnancy; Rats; Rats, Sprague-Dawley; Solubility; Uterine Contraction | 2001 |
High and low gain switches for regulation of cAMP efflux concentration: distinct roles for particulate GC- and soluble GC-cGMP-PDE3 signaling in rabbit atria.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenine; Animals; Atrial Natriuretic Factor; Biological Transport; Cardiac Pacing, Artificial; Cyclic AMP; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 2; Cyclic Nucleotide Phosphodiesterases, Type 3; Enzyme Inhibitors; Guanylate Cyclase; Heart Atria; Milrinone; Molsidomine; Myocardial Contraction; Myocytes, Cardiac; Natriuretic Peptide, C-Type; Nitric Oxide Donors; Oxadiazoles; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pyrazoles; Pyridines; Quinoxalines; Rabbits; Receptors, Cytoplasmic and Nuclear; Second Messenger Systems; Soluble Guanylyl Cyclase; Stroke Volume | 2004 |
Direct comparison of relaxation and cGMP production in human coronary by-pass grafts in response to stimulation with natriuretic peptides and a nitric oxide donor.
Topics: Adult; Aged; Aged, 80 and over; Atrial Natriuretic Factor; Coronary Artery Bypass; Cyclic GMP; Dose-Response Relationship, Drug; Female; Humans; Internal Mammary-Coronary Artery Anastomosis; Male; Mammary Arteries; Middle Aged; Molsidomine; Natriuretic Peptide, Brain; Natriuretic Peptide, C-Type; Natriuretic Peptides; Nitric Oxide Donors; Saphenous Vein; Tissue Culture Techniques; Vasodilation; Vasodilator Agents | 2006 |